Compound Semaglutide Shelf Life & Storage

Last reviewed: May 21, 2026

Last updated: May 21, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

Compound semaglutide typically remains stable for 30 days when stored at 2–8°C (refrigerated), though some licensed 503A formulations extend to 90 days. Stability depends on the specific compounding pharmacy's formulation, sterility protocols, and vial construction. Understanding shelf life and storage requirements ensures consistent dosing and treatment continuity.

For patients beginning compounded GLP-1 therapy, knowing medication stability is as important as understanding how your body may respond to it. PlexusDx emphasizes precision wellness: combining practical medication management with genetic insights that may help contextualize your individual treatment pathway with your provider.

Compounded Semaglutide Stability: What Determines How Long It Lasts

Compound semaglutide is manufactured by licensed 503A pharmacies under strict USP <797> standards. Stability is influenced by peptide concentration, preservative formulation, vial material, and headspace sterility. Most compounded preparations maintain potency for 30 days refrigerated; some reach 90 days with extended-stability formulations approved by the compounding pharmacy.

The active semaglutide molecule is sensitive to temperature fluctuations and light exposure. Each licensed pharmacy provides specific expiration guidance based on their compounding process. Patients should always reference their pharmacy's stability data—typically included in patient medication guides—rather than assuming a standard duration.

Storage Requirements and Best Practices for Compounded GLP-1 Therapy

Proper storage directly affects medication efficacy. Compounded semaglutide requires consistent refrigeration at 2–8°C (36–46°F) to maintain potency. Freezing, room-temperature exposure, or direct sunlight degrades the peptide and reduces treatment effectiveness. Most vials include a printed expiration date; exceeding this date risks reduced bioavailability.

Storage Factor	Requirement	Impact if Not Followed
Temperature	2–8°C refrigerated consistently	Peptide degradation, reduced efficacy
Light Exposure	Protect from direct sunlight and UV light	Chemical breakdown, loss of potency
Vial Integrity	Keep sealed, unopened until use	Contamination risk, compromised sterility
Freezing	Do not freeze compounded semaglutide	Crystal formation, irreversible damage
Room Temperature	Avoid storage above 8°C or outside fridge	Accelerated degradation, shortened shelf life

Comparing 30-Day and Extended-Stability Formulations

Licensed 503A pharmacies may offer both standard 30-day formulations and extended-stability options reaching 90 days. Extended-stability versions typically use enhanced preservatives and specialized vial construction. The choice depends on patient refill patterns, storage capacity, and prescriber preference. Neither formulation is superior—they serve different patient schedules.

Extended-stability formulations allow less frequent pharmacy refills and reduce the risk of medication gaps. However, they require more rigorous storage compliance and may cost slightly more. Your prescriber and pharmacy can recommend the formulation best suited to your treatment plan and lifestyle.

When Biomarkers and Genetics May Influence Your Treatment Continuity

Your genetic predispositions in peptide pathways—revealed by PlexusDx's Precision Peptide Genetic Test—may inform how your provider evaluates your individual response pattern over time. Variants in GLP1R, GIPR, and FTO genes can provide context for how your body processes GLP-1 medications, potentially affecting treatment consistency and adjustment timing.

Understanding your genetic profile may help your provider anticipate whether frequent dose adjustments, alternative formulations, or timing of refills align with your individual pathway. This insight supports a more informed conversation about which compounded semaglutide formulation (30-day or extended-stability) best fits your treatment goals and response pattern.

Safety Considerations and When to Replace Stored Medication

Always check your vial's expiration date before each injection. Expired or improperly stored semaglutide may have reduced potency, risking inadequate therapy or unpredictable effects. If a vial has been left unrefrigerated for more than 2 hours, or if the solution appears cloudy, discolored, or contains particles, do not use it—contact your pharmacy immediately.

Patient adherence to storage guidelines is critical for treatment safety and efficacy. If you travel, use a cooling case or portable medication refrigerator to maintain the 2–8°C range. Inform your healthcare provider of any storage gaps or concerns; they can adjust your refill schedule or formulation choice to match your lifestyle and ensure consistent access to your medication.

How PlexusDx Supports a More Personalized Approach

PlexusDx's Precision Peptide Genetic Test analyzes key variants (GLP1R rs6923761, GIPR rs1800437, FTO rs9939609, MC4R rs17782313) that may help contextualize your individual response predispositions in peptide pathways. This genetic context does not predict exact medication response or duration, but may help provide a framework for understanding how your body processes compounded semaglutide and whether treatment adjustments align with your genetic profile.

The Precision Peptide Genetic Test is available as a $99 add-on to any PlexusDx treatment order or as a standalone $298 test. These predispositions should be interpreted with a qualified healthcare provider—they reveal genetic risk factors and response tendencies, not guarantees. Combined with clinical markers and provider assessment, genetic insights may support more personalized medication selection and dosing strategy.

Understanding both medication stability and your individual genetic context helps create a complete picture of your GLP-1 therapy journey. Share your Precision Peptide Genetic Test results with your provider to discuss whether your compounded semaglutide formulation (30-day or extended-stability), refill schedule, and dose adjustments align with your genetic predispositions and treatment goals. This integrated approach supports more informed, individualized care.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month, or $298 standalone) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Tirzepatide Injection is $289/mo month-to-month, or from $249/mo on the 6-month plan. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

Why do two compounding pharmacies give different expiration dates for the same drug?

Because the formulations differ. The article says stability is influenced by peptide concentration, preservative formulation, vial material, and headspace sterility, and that each licensed pharmacy sets its own expiration guidance based on its compounding process. Its advice is to reference your own pharmacy's stability data, typically included in the patient medication guide, rather than assuming a single standard duration applies.

What is the difference between a standard and an extended-stability compounded formulation?

The article describes extended-stability versions as typically using enhanced preservatives and specialized vial construction, which lets them carry a longer dated life than a standard preparation. It says the practical trade-off is fewer pharmacy refills and less risk of a treatment gap, against slightly higher cost and stricter handling. It is explicit that neither is superior, and that your prescriber and pharmacy decide which fits.

What makes a peptide medication more fragile than an ordinary tablet?

Its chemistry. The article says the active semaglutide molecule is sensitive to temperature fluctuations and light exposure, and that degradation reduces potency and bioavailability. That sensitivity is why the compounding process, the vial, and the dated life all matter more here than for a simple oral tablet. Your pharmacy's own instructions are the authority on how any specific preparation should be handled.

What does the article say to do if a vial looks cloudy or has particles in it?

It says not to use it and to contact your pharmacy immediately. The same applies if the solution appears discoloured. The reasoning it gives is that a degraded or compromised preparation risks inadequate therapy or unpredictable effects rather than simply doing nothing. Questions about the condition of a specific vial are for the dispensing pharmacy, which knows that preparation's specifications.

Who should I tell if my medication has not been kept as intended?

Your healthcare provider and your pharmacy, according to this article. It says to inform your provider of any storage gaps or concerns, and that they can adjust your refill schedule or formulation choice to match your circumstances. The article's broader point is that a formulation which suits your actual routine is more likely to be handled correctly than one that fights it.

Related Reading

• Semaglutide Compound
• Compound Pharmacy Semaglutide
• Do Genetics Affect How Long My Reproductive Years Will Last
• Medvi Semaglutide

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.